Literature DB >> 15271448

Vascular control of ovarian function: ovulation, corpus luteum formation and regression.

T J Acosta1, A Miyamoto.   

Abstract

Hemodynamic changes are involved in the cyclic remodeling of ovarian structures. A transrectal color Doppler ultrasonography was used to assess the blood flow and changes in the vasculature that take place in the follicle wall and within the corpus luteum (CL) during specific physiological events such as ovulation, CL development, and CL regression in cows. To investigate the local release of vasoactive peptides, steroid hormones, and prostaglandins (PGs) in the ovarian microenvironment, the capillary membranes (0.2mm diameter and 5-10mm length) of a microdialysis system (MDS) were implanted into the follicle wall and the CL in vitro. Furthermore, in vivo experiments were conducted with the same MDS membranes surgically implanted in follicle wall or on CL along with ovarian venous and jugular catheters to collect simultaneous, real-time information on the ovarian and systemic changes in the secretion of factors regulating vascular function. Based on the results obtained from the series of in vitro and in vivo experiments, we propose that a functional "cross-talk" occurs between the vascular components (endothelial cells) and steroidogenic cells to control follicular and luteal functions in the bovine ovary.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15271448     DOI: 10.1016/j.anireprosci.2004.04.022

Source DB:  PubMed          Journal:  Anim Reprod Sci        ISSN: 0378-4320            Impact factor:   2.145


  19 in total

Review 1.  Ovulation: Parallels With Inflammatory Processes.

Authors:  Diane M Duffy; CheMyong Ko; Misung Jo; Mats Brannstrom; Thomas E Curry
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

2.  Placental Growth Factor Is Required for Ovulation, Luteinization, and Angiogenesis in Primate Ovulatory Follicles.

Authors:  Hannah R Bender; Heidi A Trau; Diane M Duffy
Journal:  Endocrinology       Date:  2018-02-01       Impact factor: 4.736

3.  Angiogenesis in the primate ovulatory follicle is stimulated by luteinizing hormone via prostaglandin E2.

Authors:  Heidi A Trau; John S Davis; Diane M Duffy
Journal:  Biol Reprod       Date:  2014-11-05       Impact factor: 4.285

4.  Prostaglandin E2 and vascular endothelial growth factor A mediate angiogenesis of human ovarian follicular endothelial cells.

Authors:  Heidi A Trau; Mats Brännström; Thomas E Curry; Diane M Duffy
Journal:  Hum Reprod       Date:  2016-01-05       Impact factor: 6.918

5.  Role of follicular estradiol-17beta in timing of luteolysis in heifers.

Authors:  Reno R Araujo; O J Ginther; Jair C Ferreira; Miller M Palhão; Mohd A Beg; Milo C Wiltbank
Journal:  Biol Reprod       Date:  2009-03-04       Impact factor: 4.285

6.  VEGFR-3 neutralization inhibits ovarian lymphangiogenesis, follicle maturation, and murine pregnancy.

Authors:  Joseph M Rutkowski; Jong Eun Ihm; Seung Tae Lee; Witold W Kilarski; Veronique I Greenwood; Miriella C Pasquier; Alexandra Quazzola; Didier Trono; Jeffrey A Hubbell; Melody A Swartz
Journal:  Am J Pathol       Date:  2013-09-13       Impact factor: 4.307

Review 7.  Biological functions of hCG and hCG-related molecules.

Authors:  Laurence A Cole
Journal:  Reprod Biol Endocrinol       Date:  2010-08-24       Impact factor: 5.211

8.  Effect of oxytocin infusion on luteal blood flow and progesterone secretion in dairy cattle.

Authors:  Christos N Brozos; Metin S Pancarci; Javier Valencia; Nikola Beindorff; Georgios Tsousis; Evaggelos Kiossis; Heinrich Bollwein
Journal:  J Vet Sci       Date:  2012-03       Impact factor: 1.672

9.  Gap junctional connexin 37 is expressed in sheep ovaries.

Authors:  Ewa Borowczyk; Mary Lynn Johnson; Jerzy J Bilski; Pawel Borowicz; Dale A Redmer; Lawrence P Reynolds; Anna T Grazul-Bilska
Journal:  Endocrine       Date:  2006-10       Impact factor: 3.925

10.  Can luteal regression be reversed?

Authors:  Carlos M Telleria
Journal:  Reprod Biol Endocrinol       Date:  2006-10-30       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.